View Item 

Show simple item record

Expression of MHC class II in T cells is associated with increased HIV-1 expression

dc.contributor.authorSaifuddin, M.en_US
dc.contributor.authorSpear, G. T.en_US
dc.contributor.authorChang, C. -H.en_US
dc.contributor.authorRoebuck, K. A.en_US
dc.date.accessioned2010-06-01T22:07:19Z
dc.date.available2010-06-01T22:07:19Z
dc.date.issued2000-08en_US
dc.identifier.citationSaifuddin, M.; Spear, G. T.; Chang, C.-H.; Roebuck, K. A. (2000). "Expression of MHC class II in T cells is associated with increased HIV-1 expression." Clinical & Experimental Immunology 121(2): 324-331. <http://hdl.handle.net/2027.42/75144>en_US
dc.identifier.issn0009-9104en_US
dc.identifier.issn1365-2249en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75144
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10931149&dopt=citationen_US
dc.format.extent123188 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ltden_US
dc.rightsBlackwell Science Ltden_US
dc.subject.otherMHC Class IIen_US
dc.subject.otherCIITAen_US
dc.subject.otherT Cell Activationen_US
dc.subject.otherHIV-1 Transcriptionen_US
dc.titleExpression of MHC class II in T cells is associated with increased HIV-1 expressionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum* Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Immunology/Microbiology, Rush University, Chicago, IL, anden_US
dc.identifier.pmid10931149en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75144/1/j.1365-2249.2000.01290.x.pdf
dc.identifier.doi10.1046/j.1365-2249.2000.01290.xen_US
dc.identifier.sourceClinical & Experimental Immunologyen_US
dc.identifier.citedreferenceZhang Z, Schuler T, Zupancic M et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4(+) T cells. Science 1999; 286: 1353 7.en_US
dc.identifier.citedreferenceChun TW, Carruth L, Finzi D et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387: 183 8.en_US
dc.identifier.citedreferencePerelson AS, Neumann AU, Markowitz M et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271: 1582 6.en_US
dc.identifier.citedreferenceFinzi D & Silliciano RF. Viral dynamics in HIV-1 infection. Cell 1998; 93: 665 71.en_US
dc.identifier.citedreferenceHo DD, Neumann AU, Perelson AS et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123 6.en_US
dc.identifier.citedreferenceWei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117 22.en_US
dc.identifier.citedreferenceStevenson M, Stanwick TL, Dempsey MP et al. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990; 9: 1551 60.en_US
dc.identifier.citedreferenceWong JK, Hezareh M, Gunthard HF et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278: 1291 5.en_US
dc.identifier.citedreferenceZack JA, Arrigo SJ, Weitsman SR et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61: 213 22.en_US
dc.identifier.citedreferenceBrown MF, Cook RG, Van M et al. Cloned human T cells synthesize Ia molecules and can function as antigen presenting cells. Hum Immunol 1984; 11: 219 28.en_US
dc.identifier.citedreferenceGerrard TL, Volkman DJ, Jurgensen CH et al. Activated human T cells can present denatured antigen. Hum Immunol 1986; 17: 416 25.en_US
dc.identifier.citedreferenceLanzavecchia A, Roosnek E, Gregory T et al. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 1988; 334: 530 2.en_US
dc.identifier.citedreferenceBrick-Ghannam C, Huang FL, Temime N et al. Protein kinase C (PKC) activation via human leucocyte antigen class II molecules. A novel regulation of PKC activity. J Biol Chem 1991; 266: 24169 75.en_US
dc.identifier.citedreferenceGreer SF, Lin J, Clarke CH et al. Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD45. J Biol Chem 1998; 273: 11970 9.en_US
dc.identifier.citedreferenceLane PJ, McConnell FM, Schieven CL et al. The role of class II molecules in human B cell activation. Association with phosphatidyl inositol turnover, protein tyrosine phosphorylation, and proliferation. J Immunol 1990; 144: 3684 92.en_US
dc.identifier.citedreferenceScholl PR & Geha RS. MHC class II signaling in B-cell activation. Immunol Today 1994; 15: 418 22.en_US
dc.identifier.citedreferenceAltomonte M, Simonelli C, Tirelli U et al. Signaling by HLA class II antigens on B cells [letter]. Immunol Today 1995; 16: 548.en_US
dc.identifier.citedreferenceTruman JP, Garban F, Choqueux C et al. HLA class II signaling mediates cellular activation and programmed cell death. Exp Hematol 1996; 24: 1409 15.en_US
dc.identifier.citedreferenceOdum N, Martin PJ, Schieven GL et al. Signal transduction by HLA-DR is mediated by tyrosine kinase(s) and regulated by CD45 in activated T cells. Hum Immunol 1991; 32: 85 94.en_US
dc.identifier.citedreferenceOdum N, Yoshizumi H, Okamoto Y et al. Signal transduction by HLA class II molecules in human T cells: induction of LFA-1-dependent and independent adhesion. Hum Immunol 1992; 35: 71 84.en_US
dc.identifier.citedreferenceOdum N, Kanner SB, Ledbetter JA et al. MHC class II molecules deliver costimulatory signals in human T cells through a functional linkage with IL-2-receptors. J Immunol 1993; 150: 5289 98.en_US
dc.identifier.citedreferenceSpertini F, Chatila T, Geha RS. Signals delivered via MHC class II molecules synergize with signals delivered via TCR/CD3 to cause proliferation and cytokine gene expression in T cells. J Immunol 1992; 149: 65 70.en_US
dc.identifier.citedreferenceTruman JP, Ericson ML, Choqueux-Seebold CJ et al. Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 1994; 6: 887 96.en_US
dc.identifier.citedreferenceFuleihan R, Spertini F, Geha RS et al. Role of protein kinase activation in the induction of B cell adhesion by MHC class II ligands. J Immunol 1992; 149: 1853 8.en_US
dc.identifier.citedreferenceMourad W, Geha RS, Chatila T. Engagement of major histocompatibility complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion. J Exp Med 1990; 172: 1513 6.en_US
dc.identifier.citedreferenceRich T, Lawler SE, Lord JM et al. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains. J Immunol 1997; 159: 3792 8.en_US
dc.identifier.citedreferenceWade WF, Davoust J, Salamero J et al. Structural compartmentalization of MHC class II signaling function. Immunol Today 1993; 14: 539 46.en_US
dc.identifier.citedreferenceArthur LO, Bess JW Jr, Sowder RCd et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992; 258: 1935 8.en_US
dc.identifier.citedreferenceHoxie JA, Fitzharris TP, Youngbar PR et al. Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol 1987; 18: 39 52.en_US
dc.identifier.citedreferenceOrentas RJ & Hildreth JE. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retrovir 1993; 9: 1157 65.en_US
dc.identifier.citedreferenceRossio JL, Bess J Jr, Henderson LE et al. HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis. AIDS Res Hum Retrovir 1995; 11: 1433 9.en_US
dc.identifier.citedreferenceCantin R, Fortin JF, Lamontagne G et al. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol 1997; 71: 1922 30.en_US
dc.identifier.citedreferenceCosma A, Blanc D, Braun J, et al. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class 1 molecules. AIDS 1999; 13: 2033 42.en_US
dc.identifier.citedreferenceSaifuddin M, Crnich C, Long T et al. Transfer of host T-cell membrane HLA-DR and CD25 to target cells by human retroviruses. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 196 202.en_US
dc.identifier.citedreferenceBoss JM. Regulation of transcription of MHC class II genes. Curr Opin Immunol 1997; 9: 107 13.en_US
dc.identifier.citedreferenceMuhlethaler-Mottet A, Otten LA, Steimle V et al. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 1997; 16: 2851 60.en_US
dc.identifier.citedreferenceSteimle V, Otten LA, Zufferey M et al. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75: 135 46.en_US
dc.identifier.citedreferenceWright KL, Chin KC, Linhoff M et al. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc Natl Acad Sci USA 1998; 95: 6267 72.en_US
dc.identifier.citedreferenceMorikawa S, Tatsumi E, Baba M et al. Two E-rosette-forming lymphoid cell lines. Int J Cancer 1978; 21: 166 70.en_US
dc.identifier.citedreferenceSaifuddin M, Parker CJ, Peeples ME et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 1995; 182: 501 9.en_US
dc.identifier.citedreferenceChang CH, Fontes JD, Peterlin M et al. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994; 180: 1367 74.en_US
dc.identifier.citedreferenceRoebuck KA, Brenner DA, Kagnoff MF. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J Clin Invest 1993; 92: 1336 48.en_US
dc.identifier.citedreferenceOsborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989; 86: 2336 40.en_US
dc.identifier.citedreferenceUgolini S, Mondor I, Sattentau QJ. HIV-1 attachment: another look. Trends Microbiol 1999; 7: 144 9.en_US
dc.identifier.citedreferenceMondor I, Ugolini S, Sattentau QJ. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J Virol 1998; 72: 3623 34.en_US
dc.identifier.citedreferenceRoebuck KA & Saifuddin M. Regulation of HIV-1 transcription [Review]. Gene Expr 1999; 8: 67 84.en_US
dc.identifier.citedreferenceRabbi MF, Saifuddin M, Gu DS et al. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins. Virology 1997; 233: 235 45.en_US
dc.identifier.citedreferenceRoebuck KA, Gu DS, Kagnoff MF. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS 1996; 10: 819 26.en_US
dc.identifier.citedreferenceVan Lint C, Amella CA, Emiliani S et al. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J Virol 1997; 71: 6113 27.en_US
dc.identifier.citedreferenceOstrowski MA, Chun TW, Justement SJ et al. Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J Virol 1999; 73: 6430 5.en_US
dc.identifier.citedreferenceHazenberg MD, Stuart JW, Otto SA et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000; 95: 249 55.en_US
dc.identifier.citedreferenceO'Brien WA, Grovit-Ferbas K, Namazi A et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86: 1082 9.en_US
dc.identifier.citedreferenceWeissman D, Barker TD, Fauci AS. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 1996; 183: 687 92.en_US
dc.identifier.citedreferenceStaprans SI, Hamilton BL, Follansbee SE et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995; 182: 1727 37.en_US
dc.identifier.citedreferenceMahalingam M, Peakman M, Davies ET et al. T cell activation and disease severity in HIV infection. Clin Exp Immunol 1993; 93: 337 43.en_US
dc.identifier.citedreferenceMahalingam M, Pozniak A, McManus TJ et al. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes. Clin Exp Immunol 1995; 102: 481 6.en_US
dc.identifier.citedreferencePeakman M, Mahalingam M, Pozniak A et al. Markers of immune cell activation and disease progression. Cell activation in HIV disease. Adv Exp Med Biol 1995; 374: 17 26.en_US
dc.identifier.citedreferenceLekutis C, Shiver JW, Liu MA et al. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. J Immunol 1997; 158: 4471 7.en_US
dc.identifier.citedreferenceMarrack P, Endres R, Shimonkevitz R et al. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J Exp Med 1983; 158: 1077 91.en_US
dc.identifier.citedreferenceShaw S, Goldstein G, Springer TA et al. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the ‘avidity’ of CTL–target interaction. J Immunol 1985; 134: 3019 26.en_US
dc.identifier.citedreferenceNabel G & Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells [published erratum appears in Nature 1990:178]. Nature 1987; 326: 711 3.en_US
dc.identifier.citedreferenceSaarloos MN, Sullivan BL, Czerniewski MA et al. Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1. J Virol 1997; 71: 1640 3.en_US
dc.identifier.citedreferenceDoyle C & Strominger JL. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987; 330: 256 9.en_US
dc.identifier.citedreferenceFleury SG, Croteau G, Sekaly RP. CD4 and CD8 recognition of class II and class I molecules of the major histocompatibility complex. Semin Immunol 1991; 3: 177 85.en_US
dc.identifier.citedreferenceKinch MS, Sanfridson A, Doyle C. The protein tyrosine kinase p56lck regulates cell adhesion mediated by CD4 and major histocompatibility complex class II proteins. J Exp Med 1994; 180: 1729 39.en_US
dc.identifier.citedreferenceDalgleish AG, Beverley PC, Clapham PR et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312: 763 7.en_US
dc.identifier.citedreferenceMann DL, Read-Connole E, Arthur LO et al. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J Immunol 1988; 141: 1131 6.en_US
dc.identifier.citedreferencePlaeger S, Bass HZ, Nishanian P et al. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin Immunol 1999; 90: 238 46.en_US
dc.identifier.citedreferenceWrightham M, Schimpf A, Pennington TH et al. HIV induces modulation of functionally important cellular antigens. Clin Exp Immunol 1991; 85: 75 79.en_US
dc.identifier.citedreferenceFauci AS. Immunopathogenesis of HIV infection. J Acquir Immune Defic Syndr 1993; 6: 655 62.en_US
dc.identifier.citedreferenceHaynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271: 324 8.en_US
dc.identifier.citedreferenceKamoun M, Zerva L, Sloan S et al. Induction of HLA class II molecules on human T cells: relationship to immunoregulation and the pathogenesis of AIDS. DNA Cell Biol 1992; 11: 265 8.en_US
dc.identifier.citedreferencePantaleo G, Graziosi C, Demarest JF et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362: 355 8.en_US
dc.identifier.citedreferenceKanazawa S, Okamoto T, Peterlin BM. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 2000; 12: 61 70.en_US
dc.identifier.citedreferenceSaifuddin M, Roebuck KA, Chang C-H et al. Activation of HIV-1 transcription by the MHC class II transactivator. J Immunol (Cutt Edg) 2000; 164: 3941 5.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2249.2000.01290.x.pdf
Size:
120.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.